Navigation Links
Neuropathy Treatment Cited for Efficacy, Convenience, Economy
Date:7/12/2011

LAS VEGAS, July 12, 2011 /PRNewswire/ -- Pure Biomed LLC launched a full line of non-prescription, botanical, topical foot, hand, body and facial treatments on April 1, 2011.  In only three months, Reunion brand has proven useful in the relief of nerve pain caused by diabetes, chemotherapy, fibromyalgia and pinched nerves for patients across the U.S. and Canada.

While Reunion's flagship product is Intense Spot Relief oil, the lotions, creams and gels have far exceeded expectations both in immediate pain relief as well as being cumulative and preventing episodic nerve pain flare attacks.

Reunion products were developed from the ground up in oils, lotions and creams specifically for sufferers of nerve pain.  The entire daily usage product line contains Reunion proprietary essential oil formulation, in reduced concentrations.  Skin care products may be used throughout the day to relieve pain, moisturize and cleanse.

Intense Spot Relief oil is a formulation of nine tropical oils each selected for its unique benefits and extracted using state of art processes for absolute purity and efficacy.  The daily usage products utilize a nano-technology delivery system for encapsulation of the active ingredients and quick transdermal penetration.

Due to the groundswell of 5-Star Customer Reviews, Pure Biomed was asked to participate in PAINWeek 2011.  Reunion products are the only botanical pain relief products included in the Conference and are exhibited at the request of Aventineco management. PAINWeek is the National Conference on Pain for the Frontline Practitioner.

"We look forward to participating in PAINWeek," said Karl Douglass, President of Pure Biomed LLC.  "We are especially honored to exhibit along side every major pharmaceutical company with neuropathy pain relief products and feel this is a validation by pain relief professionals of the effectiveness of Reunion products."  Reunion skin care products are exclusive to Pure Biomed LLC.  Reunion products are available to consumers only on the Internet at www.ReunionPN.com thus eliminating markups by OTC marketers.

Reunion™ products were developed and produced in cooperation with a U.S. manufacturer of super-premium skin care products.  Daily use treatments may be used frequently.  Protection from pain and skin conditioning are both cumulative and preventative.  Men and women with nerve damaged/impaired immune systems will appreciate the benefits of Reunion.


'/>"/>
SOURCE Pure Biomed LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
4. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
5. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
6. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
7. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
8. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
9. Arcion Therapeutics Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN)
10. Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
11. Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... and PUNE, India , February 22, 2017 ... Market Research, titled, "Automated Radio Synthesis Modules Market: Global Opportunity ... radiosynthesis modules market was worth $20 million in 2015 and ... CAGR of 6.6% from 2016 to 2022. North ... of both market revenues and unit volumes, whereas ...
(Date:2/22/2017)... Research and Markets has announced the ... Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, ... 2022" report to their offering. ... The global psoriasis drugs market ... This report provides a detailed analysis of the current ...
(Date:2/22/2017)... WASHINGTON , Feb. 22, 2017 The ... in the U.S. Senate and House of Representatives that ... Pharmacy Benefit Managers (PBMs) -- from extracting retroactive direct ... long term care (LTC) pharmacies and the Medicare program. ... Moore Capito (R-WV) and Jon Tester ...
Breaking Medicine Technology:
(Date:2/22/2017)... Fla. (PRWEB) , ... February 22, 2017 , ... ... is just as effective on smaller and sometimes harder to reach ones, according ... were presented at the International Stroke Conference in Houston by Ricardo A. Hanel, ...
(Date:2/22/2017)... ... 22, 2017 , ... The first-ever National Heart Valve Disease ... individuals join together to increase recognition about the risks of heart valve disease ... we mark a nationwide movement to raise awareness about a disease that has ...
(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... North Carolina (PRWEB) , ... February 22, 2017 , ... ... of cats and 54% of dogs, according to the Association for Pet Obesity Prevention ... disagreed on key pet food issues such as the benefits of corn and grains, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... Patient Safety, patient advocates stress that the patient context (age, illness and life ... as reasons to mitigate their occurrence. In addition, all too often, ...
Breaking Medicine News(10 mins):